Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP) (U19)
Post Date
June 4th 2014
Application Due Date
November 18th 2014
Funding Opportunity Number
RFA-AI-14-025
CFDA Number(s)
93.242
93.855
93.856
Funding Instrument Type(s)
Cooperative Agreement
Funding Activity Categories
Number of Awards
1
Eligibility Categories
State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Funding
-
Estimated Total Funding:
$4700000
-
Award Range:
$None - $2600000
Grant Description
The purpose of this Funding Opportunity Announcement is to solicit applications from single institutions and consortia of institutions to participate in the Integrated Preclinical Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP).The objective of each IPCP-MBP application is to create an integrated and iterative multi-disciplinary application with the goal of developing a microbicide, PreExposure Prophylaxis (PrEP), or Multipurpose Prevention Technology (MPT) non-vaccine biomedical prevention (nBP) product or strategy, for use in the male and/or female genital and gastrointestinal (GI) tracts to prevent HIV acquisition/transmission. Products and strategies may be delivered by a variety of drug delivery systems (DDS), including gels, films, quick dissolving tablets, intravaginal rings (IVR), implants, oral, and/or injection. This FOA contains significant modifications to previous iterations of the Integrated Preclinical Clinical Program FOA.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
-
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-025.html
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: